Montelukast Intermediate Market to Witness Robust Expansion by 2029

Montelukast Intermediate Market is anticipated to grow at a significant CAGR during the forecast period. The major factors responsible for the growth of the market during the forecast period include an increase in demand for the montelukast intermediate from API (Active Pharmaceutical Ingredient) manufacturers, an increase in presence of generics as well as rising prevalence of asthma, bronchospasm, allergic rhinitis, and urticaria.

The montelukast intermediates are used to prevent wheezing, difficulty in breathing, chest tightness, and coughing caused by asthma. Moreover, montelukast is designated for the handling of periodic and recurrent allergic rhinitis. The important aspects pouring the market's evolution include globally rising commonness of allergic rhinitis, urticaria, asthma, bronchospasm, burgeoning pharmaceutical industry attached with the rising call from active pharmaceutical ingredients (APIs) manufacturers, and montelukast patent expiration.

The global montelukast intermediate market analysis includes some of the key market players such as Aurobindo Pharma Ltd., Glenmark Pharmaceuticals Ltd., and Merck & Co., Inc., among others. To maintain a strong position in the market, the market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in November 2020, Mylan received clearance from the US Federal Trade Commission (FTC) to advance the merger of Pfizer's Upjohn generics unit.

To Request a Sample of our Report on Montelukast Intermediate Market: https://www.omrglobal.com/request-sample/montelukast-intermediate-market

Market Coverage

· The market number available for - 2022-2030

· Base year- 2022

· Forecast period- 2022-2030

· Segment Covered

· Regions Covered- Globally

· Competitive Landscape: Aurobindo Pharma Ltd., Glenmark Pharmaceuticals Ltd., and Merck & Co., Inc., among others.

Montelukast Intermediate Market Report by Segment

By Application

• Asthma

• Allergic Rhinitis

• Bronchospasm

• Urticaria

A full Report of Montelukast Intermediate Market is Available at: https://www.omrglobal.com/industry-reports/montelukast-intermediate-market

Montelukast Intermediate Market by Regional Analysis

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.